INCREASED SARCOLEMMAL PERMEABILITY IN CARDIOMYOPATHY IN HYPERTROPHIED SHR MYOCARDIUM
To study the membrane changes in the myocardium, the sarcolemmal permeability of 16-week-old SHR and age-matched WKY myocardium was examined morphologically using horseradish peroxidase (HRP) on the first and fourth day after doxorubicin administration. No HRP was seen in either saline-treated contr...
Gespeichert in:
Veröffentlicht in: | Journal of Toxicologic Pathology 1994/06/30, Vol.7(2), pp.191-198 |
---|---|
Hauptverfasser: | , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 198 |
---|---|
container_issue | 2 |
container_start_page | 191 |
container_title | Journal of Toxicologic Pathology |
container_volume | 7 |
creator | Torii, Mikinori Inoue, Satoshi Matsushima, Shuuichi Fuji, Satoshi Maruyama, Toshiyuki Muraoka, Yoshihiro Ito, Hiroyuki |
description | To study the membrane changes in the myocardium, the sarcolemmal permeability of 16-week-old SHR and age-matched WKY myocardium was examined morphologically using horseradish peroxidase (HRP) on the first and fourth day after doxorubicin administration. No HRP was seen in either saline-treated controls or doxorubicin-treated WKY on the first day. On the fourth day, the doxorubicin-treated WKY showed, HRP around the myocytes due to an increase in the vascular permeability, whereas, the HRP-reactant product was not seen within the sarcoplasm. Electron micros-copy revealed osmiophilic, fine granular HRP-reactant products in the extracellular space of the WKY myocardium on the fourth day. On the other hand, in doxorubicin-treated SHR myocardium, HRP was seen in a portion of the papillary muscle or myocardial cells in the anterior wall on the first day and HRP-positive myocytes were scattered in the anterio-lateral wall at the fourth day. Cross striations were still visible within some HRP-positive myocytes of SHR. Electron microscopy also showed HRP-reactant products, not only in sarcotubules of normal-appearance myocytes, but also in myofibrils and/or mitochondria of highly degenerated myocytes. These results demonstrate the increase in the mem-brane permeability in the SHR myocardium, probably due to genetical disadvantage of the defense system and a proneness for membrane lipid peroxidation. |
doi_str_mv | 10.1293/tox.7.191 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_journals_1467357501</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>3153865781</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3621-c6579557ba1886b727082efcc9d6087cbc50ed78d96efe9482f3e6dac0f83d623</originalsourceid><addsrcrecordid>eNo90E1PwjAYB_DGaCKiB7_BEk8ehu1K3451TrdkY2SMRE7N6DqFIMNuJPrtLWA4NG36_J72yR-AewRHKBD4qW9_RmyEBLoAA8Q58gUi75dgAAUau7Pg1-Cm69YQBgwSPABlMgmLSM6iF28mizBPoyyTqTeNiiySz0malAsvmXihLF6SPFvkU1nGx5t44UxZ5NM4OfTGheeqRzbPbsFVU206c_e_D8H8NSrD2E_ztySUqa8xDZCvKWGCELas3KR0ydxIPDCN1qKmkDO91ASamvFaUNMYMeZBgw2tKw0bjmsa4CF4OL27s-333nS9Wrd7u3VfKjSmDBNGIHLq8aS0bbvOmkbt7Oqrsr8KQXUITbnQFFMuNGflya67vvowZ1nZfqU35iBdhtzp4Lhcz7mmPyurzBb_Af3bb5c</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1467357501</pqid></control><display><type>article</type><title>INCREASED SARCOLEMMAL PERMEABILITY IN CARDIOMYOPATHY IN HYPERTROPHIED SHR MYOCARDIUM</title><source>J-STAGE Free</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><creator>Torii, Mikinori ; Inoue, Satoshi ; Matsushima, Shuuichi ; Fuji, Satoshi ; Maruyama, Toshiyuki ; Muraoka, Yoshihiro ; Ito, Hiroyuki</creator><creatorcontrib>Torii, Mikinori ; Inoue, Satoshi ; Matsushima, Shuuichi ; Fuji, Satoshi ; Maruyama, Toshiyuki ; Muraoka, Yoshihiro ; Ito, Hiroyuki</creatorcontrib><description>To study the membrane changes in the myocardium, the sarcolemmal permeability of 16-week-old SHR and age-matched WKY myocardium was examined morphologically using horseradish peroxidase (HRP) on the first and fourth day after doxorubicin administration. No HRP was seen in either saline-treated controls or doxorubicin-treated WKY on the first day. On the fourth day, the doxorubicin-treated WKY showed, HRP around the myocytes due to an increase in the vascular permeability, whereas, the HRP-reactant product was not seen within the sarcoplasm. Electron micros-copy revealed osmiophilic, fine granular HRP-reactant products in the extracellular space of the WKY myocardium on the fourth day. On the other hand, in doxorubicin-treated SHR myocardium, HRP was seen in a portion of the papillary muscle or myocardial cells in the anterior wall on the first day and HRP-positive myocytes were scattered in the anterio-lateral wall at the fourth day. Cross striations were still visible within some HRP-positive myocytes of SHR. Electron microscopy also showed HRP-reactant products, not only in sarcotubules of normal-appearance myocytes, but also in myofibrils and/or mitochondria of highly degenerated myocytes. These results demonstrate the increase in the mem-brane permeability in the SHR myocardium, probably due to genetical disadvantage of the defense system and a proneness for membrane lipid peroxidation.</description><identifier>ISSN: 0914-9198</identifier><identifier>EISSN: 1881-915X</identifier><identifier>EISSN: 1347-7404</identifier><identifier>DOI: 10.1293/tox.7.191</identifier><language>eng</language><publisher>Tokyo: JAPANESE SOCIETY OF TOXICOLOGIC PATHOLOGY</publisher><subject>Hypercontraction ; Myocardial hypertrophy</subject><ispartof>Journal of Toxicologic Pathology, 1994/06/30, Vol.7(2), pp.191-198</ispartof><rights>The Japanese Society of Toxicologic Pathology</rights><rights>Copyright Japan Science and Technology Agency 1994</rights><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3621-c6579557ba1886b727082efcc9d6087cbc50ed78d96efe9482f3e6dac0f83d623</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,777,781,1877,4010,27904,27905,27906</link.rule.ids></links><search><creatorcontrib>Torii, Mikinori</creatorcontrib><creatorcontrib>Inoue, Satoshi</creatorcontrib><creatorcontrib>Matsushima, Shuuichi</creatorcontrib><creatorcontrib>Fuji, Satoshi</creatorcontrib><creatorcontrib>Maruyama, Toshiyuki</creatorcontrib><creatorcontrib>Muraoka, Yoshihiro</creatorcontrib><creatorcontrib>Ito, Hiroyuki</creatorcontrib><title>INCREASED SARCOLEMMAL PERMEABILITY IN CARDIOMYOPATHY IN HYPERTROPHIED SHR MYOCARDIUM</title><title>Journal of Toxicologic Pathology</title><addtitle>J Toxicol Pathol</addtitle><description>To study the membrane changes in the myocardium, the sarcolemmal permeability of 16-week-old SHR and age-matched WKY myocardium was examined morphologically using horseradish peroxidase (HRP) on the first and fourth day after doxorubicin administration. No HRP was seen in either saline-treated controls or doxorubicin-treated WKY on the first day. On the fourth day, the doxorubicin-treated WKY showed, HRP around the myocytes due to an increase in the vascular permeability, whereas, the HRP-reactant product was not seen within the sarcoplasm. Electron micros-copy revealed osmiophilic, fine granular HRP-reactant products in the extracellular space of the WKY myocardium on the fourth day. On the other hand, in doxorubicin-treated SHR myocardium, HRP was seen in a portion of the papillary muscle or myocardial cells in the anterior wall on the first day and HRP-positive myocytes were scattered in the anterio-lateral wall at the fourth day. Cross striations were still visible within some HRP-positive myocytes of SHR. Electron microscopy also showed HRP-reactant products, not only in sarcotubules of normal-appearance myocytes, but also in myofibrils and/or mitochondria of highly degenerated myocytes. These results demonstrate the increase in the mem-brane permeability in the SHR myocardium, probably due to genetical disadvantage of the defense system and a proneness for membrane lipid peroxidation.</description><subject>Hypercontraction</subject><subject>Myocardial hypertrophy</subject><issn>0914-9198</issn><issn>1881-915X</issn><issn>1347-7404</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1994</creationdate><recordtype>article</recordtype><recordid>eNo90E1PwjAYB_DGaCKiB7_BEk8ehu1K3451TrdkY2SMRE7N6DqFIMNuJPrtLWA4NG36_J72yR-AewRHKBD4qW9_RmyEBLoAA8Q58gUi75dgAAUau7Pg1-Cm69YQBgwSPABlMgmLSM6iF28mizBPoyyTqTeNiiySz0malAsvmXihLF6SPFvkU1nGx5t44UxZ5NM4OfTGheeqRzbPbsFVU206c_e_D8H8NSrD2E_ztySUqa8xDZCvKWGCELas3KR0ydxIPDCN1qKmkDO91ASamvFaUNMYMeZBgw2tKw0bjmsa4CF4OL27s-333nS9Wrd7u3VfKjSmDBNGIHLq8aS0bbvOmkbt7Oqrsr8KQXUITbnQFFMuNGflya67vvowZ1nZfqU35iBdhtzp4Lhcz7mmPyurzBb_Af3bb5c</recordid><startdate>1994</startdate><enddate>1994</enddate><creator>Torii, Mikinori</creator><creator>Inoue, Satoshi</creator><creator>Matsushima, Shuuichi</creator><creator>Fuji, Satoshi</creator><creator>Maruyama, Toshiyuki</creator><creator>Muraoka, Yoshihiro</creator><creator>Ito, Hiroyuki</creator><general>JAPANESE SOCIETY OF TOXICOLOGIC PATHOLOGY</general><general>Japan Science and Technology Agency</general><scope>AAYXX</scope><scope>CITATION</scope><scope>7U7</scope><scope>C1K</scope></search><sort><creationdate>1994</creationdate><title>INCREASED SARCOLEMMAL PERMEABILITY IN CARDIOMYOPATHY IN HYPERTROPHIED SHR MYOCARDIUM</title><author>Torii, Mikinori ; Inoue, Satoshi ; Matsushima, Shuuichi ; Fuji, Satoshi ; Maruyama, Toshiyuki ; Muraoka, Yoshihiro ; Ito, Hiroyuki</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3621-c6579557ba1886b727082efcc9d6087cbc50ed78d96efe9482f3e6dac0f83d623</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1994</creationdate><topic>Hypercontraction</topic><topic>Myocardial hypertrophy</topic><toplevel>online_resources</toplevel><creatorcontrib>Torii, Mikinori</creatorcontrib><creatorcontrib>Inoue, Satoshi</creatorcontrib><creatorcontrib>Matsushima, Shuuichi</creatorcontrib><creatorcontrib>Fuji, Satoshi</creatorcontrib><creatorcontrib>Maruyama, Toshiyuki</creatorcontrib><creatorcontrib>Muraoka, Yoshihiro</creatorcontrib><creatorcontrib>Ito, Hiroyuki</creatorcontrib><collection>CrossRef</collection><collection>Toxicology Abstracts</collection><collection>Environmental Sciences and Pollution Management</collection><jtitle>Journal of Toxicologic Pathology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Torii, Mikinori</au><au>Inoue, Satoshi</au><au>Matsushima, Shuuichi</au><au>Fuji, Satoshi</au><au>Maruyama, Toshiyuki</au><au>Muraoka, Yoshihiro</au><au>Ito, Hiroyuki</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>INCREASED SARCOLEMMAL PERMEABILITY IN CARDIOMYOPATHY IN HYPERTROPHIED SHR MYOCARDIUM</atitle><jtitle>Journal of Toxicologic Pathology</jtitle><addtitle>J Toxicol Pathol</addtitle><date>1994</date><risdate>1994</risdate><volume>7</volume><issue>2</issue><spage>191</spage><epage>198</epage><pages>191-198</pages><issn>0914-9198</issn><eissn>1881-915X</eissn><eissn>1347-7404</eissn><abstract>To study the membrane changes in the myocardium, the sarcolemmal permeability of 16-week-old SHR and age-matched WKY myocardium was examined morphologically using horseradish peroxidase (HRP) on the first and fourth day after doxorubicin administration. No HRP was seen in either saline-treated controls or doxorubicin-treated WKY on the first day. On the fourth day, the doxorubicin-treated WKY showed, HRP around the myocytes due to an increase in the vascular permeability, whereas, the HRP-reactant product was not seen within the sarcoplasm. Electron micros-copy revealed osmiophilic, fine granular HRP-reactant products in the extracellular space of the WKY myocardium on the fourth day. On the other hand, in doxorubicin-treated SHR myocardium, HRP was seen in a portion of the papillary muscle or myocardial cells in the anterior wall on the first day and HRP-positive myocytes were scattered in the anterio-lateral wall at the fourth day. Cross striations were still visible within some HRP-positive myocytes of SHR. Electron microscopy also showed HRP-reactant products, not only in sarcotubules of normal-appearance myocytes, but also in myofibrils and/or mitochondria of highly degenerated myocytes. These results demonstrate the increase in the mem-brane permeability in the SHR myocardium, probably due to genetical disadvantage of the defense system and a proneness for membrane lipid peroxidation.</abstract><cop>Tokyo</cop><pub>JAPANESE SOCIETY OF TOXICOLOGIC PATHOLOGY</pub><doi>10.1293/tox.7.191</doi><tpages>8</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0914-9198 |
ispartof | Journal of Toxicologic Pathology, 1994/06/30, Vol.7(2), pp.191-198 |
issn | 0914-9198 1881-915X 1347-7404 |
language | eng |
recordid | cdi_proquest_journals_1467357501 |
source | J-STAGE Free; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals |
subjects | Hypercontraction Myocardial hypertrophy |
title | INCREASED SARCOLEMMAL PERMEABILITY IN CARDIOMYOPATHY IN HYPERTROPHIED SHR MYOCARDIUM |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-19T10%3A11%3A24IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=INCREASED%20SARCOLEMMAL%20PERMEABILITY%20IN%20CARDIOMYOPATHY%20IN%20HYPERTROPHIED%20SHR%20MYOCARDIUM&rft.jtitle=Journal%20of%20Toxicologic%20Pathology&rft.au=Torii,%20Mikinori&rft.date=1994&rft.volume=7&rft.issue=2&rft.spage=191&rft.epage=198&rft.pages=191-198&rft.issn=0914-9198&rft.eissn=1881-915X&rft_id=info:doi/10.1293/tox.7.191&rft_dat=%3Cproquest_cross%3E3153865781%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1467357501&rft_id=info:pmid/&rfr_iscdi=true |